LON:GENI GENinCode (GENI) Share Price, News & Analysis GBX 0.89 -0.01 (-1.22%) As of 08/14/2026 10:25 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About GENinCode Stock (LON:GENI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GENinCode alerts:Sign Up Key Stats Today's Range 0.85▼ 0.9250-Day Range 0.76▼ 152-Week Range 0.75▼ 5.50Volume2.17 million shsAverage Volume5.44 million shsMarket Capitalization£6.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Read More Receive GENI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GENI Stock News HeadlinesGENinCode PLCJuly 30, 2026 | marketwatch.comGENinCode Shareholders Approve All Resolutions at Annual General MeetingJuly 1, 2026 | tipranks.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.August 15 at 1:00 AM | Base Camp Trading (Ad)AIM Market Roundup: Marechale Capital, Genincode, BoohooJune 5, 2026 | uk.finance.yahoo.comGENinCode slumps after it reprices optionsMay 7, 2026 | uk.finance.yahoo.comAIM Market Roundup: Phoenix Copper, Pipehawk, GenincodeFebruary 25, 2026 | uk.finance.yahoo.comGENinCode Raises £4.1m Following Completion of WRAP Retail OfferJanuary 26, 2026 | tipranks.comTRADING UPDATES: GENinCode to raise funds via placing and subscriptionJanuary 21, 2026 | lse.co.ukSee More Headlines GENI Stock Analysis - Frequently Asked Questions How have GENI shares performed this year? GENinCode's stock was trading at GBX 2.50 on January 1st, 2026. Since then, GENI shares have decreased by 64.4% and is now trading at GBX 0.89. How were GENinCode's earnings last quarter? GENinCode Plc (LON:GENI) announced its quarterly earnings results on Monday, June, 8th. The company reported ($2.08) EPS for the quarter. The business earned $3.08 million during the quarter. GENinCode had a negative net margin of 185.47% and a negative trailing twelve-month return on equity of 409.40%. How do I buy shares of GENinCode? Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of GENinCode own? Based on aggregate information from My MarketBeat watchlists, some other companies that GENinCode investors own include Qualcomm (QCOM), Sound Energy (SOU), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID) and Plug Power (PLUG). Company Calendar Last Earnings6/08/2026Today8/15/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolLON:GENI CIKN/A Webwww.genincode.com Phone44 1865 955 847FaxN/AEmployees2,300Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (2.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£6.10 million Net Margins-185.47% Pretax MarginN/A Return on Equity-409.40% Return on Assets-63.99% Debt Debt-to-Equity Ratio117.74 Current Ratio0.93 Quick Ratio15.89 Sales & Book Value Annual Sales£3.08 million Price / Sales2.18 Cash FlowGBX 1.07 per share Price / Cash Flow0.83 Book ValueGBX 1.63 per share Price / Book0.55Miscellaneous Outstanding Shares753,041,000Free FloatN/AMarket Cap£6.69 million OptionableNot Optionable Beta0.56 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (LON:GENI) was last updated on 8/15/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GENI Stock Alerts